Danna nan don nuna banners ɗin ku akan wannan shafin kuma ku biya kawai don nasara

Labaran Waya

Sabon Maganin Tissue Na Bioengineered don Magance Ciwon Ciwon sukari Na 1

Written by edita

Aspect Biosystems ya sanar da haɗin gwiwa tare da JDRF, jagorar bincike da ƙungiyar bayar da shawarwari na nau'in ciwon sukari na 1 na duniya (T1D).          

Haɗin gwiwar JDRF-Aspect yana goyan bayan mayar da hankali kan Haɓaka na haɓaka ƙwayar ƙwayar cuta ta ƙwayoyin cuta don nau'in ciwon sukari na 1 wanda zai ba da 'yancin kai na insulin da sarrafa sukarin jini ba tare da buƙatar hana rigakafi na yau da kullun ba. Baya ga kudade, JDRF kuma tana ba da gudummawar dabarun tallafi ta hanyar zurfin gwaninta da babban hanyar sadarwa a fagen ciwon sukari.

Al'amari yana yin amfani da fasahar sa ta bioprinting, sel warkewa, da kimiyyar kayan aiki don ƙirƙirar bututun magungunan nama wanda ke maye gurbin ko gyara ayyukan gaɓoɓin gaɓoɓi. Waɗannan magungunan an tsara su da hankali don su kasance masu aiki ta hanyar ilimin halitta, masu kariya, kuma sun dace da dashen fiɗa don kula da cututtuka kamar nau'in ciwon sukari na 1.

"Sama da shekaru 20, JDRF ta kasance jagora a cikin binciken binciken nama na ƙwayar cuta don nau'in ciwon sukari na 1," in ji Esther Latres, Mataimakin Mataimakin Shugaban Bincike a JDRF. "Wannan haɗin gwiwar tallafin kuɗi tare da Aspect Biosystems zai tallafawa da ci gaba da ci gaban kimiyya a fagen kuma ba shakka zai kai mu kusa da neman magani."

Tamer Mohamed, Shugaba a Aspect Biosystems, ya ce "Tare da JDRF, mun daidaita kan manufa don samar da maganin warkewa ga miliyoyin marasa lafiya a duniya waɗanda ke fama da ciwon sukari na 1." "Wannan haɗin gwiwa zai taimaka wajen ci gaba da aiwatar da tsarin nama na pancreatic da kuma kawo mana mataki kusa da gwajin ɗan adam."

Shafin Farko

Game da marubucin

edita

Edita a shugaba na eTurboNew ita ce Linda Hohnholz. Ta dogara ne a HQ eTN a Honolulu, Hawaii.

Leave a Comment

Share zuwa...